Learn more about lenacapavir, the most effective HIV treatment and prevention drug, and how its cost could cause a setback.

The United States has approved a twice-a-year jab that almost entirely protects against HIV in what’s being hailed as a ...

US approves breakthrough HIV jab – but aid cuts mean it may not get to millions in need - FDA approval paves the way for the ...

A drug with the potential to drastically curb the HIV epidemic just cleared its first regulatory hurdle. On Wednesday, the Food and Drug Administration approved lenacapavir for the prevention of HIV.

A twice-yearly injectable drug for the prevention of HIV infection has been approved by the United States’ Food and Drug ...

Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response ...

On Wednesday, the Food and Drug Administration approved a highly effective, injectable drug to help prevent the transmission ...

A major win in the fight against HIV infections. The Food and Drug Administration approved a new twice-a-year shot to prevent ...

A United Nations agency has urged the pharmaceutical company Gilead Sciences to lower the price of the long acting antiviral treatment lenacapavir following the US Food and Drug Administration (FDA)’s ...

Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response ...

FDA approves Yeztugo HIV prevention injection showing 96% efficacy in clinical trials, but $14,000 cost creates significant access barriers for patients.

The Food and Drug Administration has approved lenacapavir, a breakthrough medication that reduces the risk of contracting HIV ...